Catalyst Pharmaceuticals (CPRX) Gains from Investment Securities (2011 - 2026)
Catalyst Pharmaceuticals posted quarterly Gains from Investment Securities of $12.4 million for Q1 2026, up 2333.51% year-on-year from $510956.0 in Q1 2025, and up 1263.4% on a QoQ basis from $912000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 16 years of Gains from Investment Securities data on file, last reported at $12.4 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 2333.51% year-over-year to $12.4 million; the trailing twelve-month figure through Mar 2026 stood at $12.4 million (up 2333.51% YoY), and the FY2025 full-year result was $12.2 million, down 6.91% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $12.4 million, up from $912000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $31.1 million in Q4 2022 and bottomed at $35693.0 in Q2 2024.
- The 5-year median for Gains from Investment Securities is $633000.0 (2022), against an average of $6.2 million.
- The widest annual swing landed in 2024, when Gains from Investment Securities plunged 97.87%; it then soared 34015.98% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $31.1 million in 2022, then sank by 30.15% to $21.7 million in 2023, then slumped by 97.87% to $464000.0 in 2024, then surged by 96.55% to $912000.0 in 2025, then jumped by 1263.4% to $12.4 million in 2026.
- The last three Gains from Investment Securities figures came in at $12.4 million (Q1 2026), $912000.0 (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.43 Mn |
| Mar 31, 2026 | 12.43 Mn |
| Dec 31, 2025 | 912,000.00 |
| Dec 31, 2025 | 912,000.00 |
| Sep 30, 2025 | 11.33 Mn |
| Sep 30, 2025 | 11.33 Mn |
| Jun 30, 2025 | 12.18 Mn |
| Jun 30, 2025 | 12.18 Mn |
| Mar 31, 2025 | 510,956.00 |
| Mar 31, 2025 | 510,956.00 |
| Dec 31, 2024 | 464,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Sep 30, 2024 | 35,693.00 |
| Sep 30, 2024 | 35,693.00 |
| Jun 30, 2024 | 35,693.00 |
| Jun 30, 2024 | 35,693.00 |
| Mar 31, 2024 | 204,000.00 |
| Mar 31, 2024 | 204,000.00 |
| Dec 31, 2023 | 21.74 Mn |
| Dec 31, 2023 | 21.74 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 477,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Dec 31, 2022 | 31.12 Mn |
| Dec 31, 2022 | 31.12 Mn |
| Sep 30, 2022 | 129,000.00 |
| Sep 30, 2022 | 129,000.00 |
| Jun 30, 2022 | 633,000.00 |
| Jun 30, 2022 | 633,000.00 |
| Dec 31, 2021 | 136,000.00 |
| Dec 31, 2021 | 136,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Mar 31, 2021 | -76,000.00 |
| Mar 31, 2021 | -76,000.00 |
| Dec 31, 2020 | 72,000.00 |
| Dec 31, 2020 | 72,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | -85,000.00 |
| Jun 30, 2020 | -85,000.00 |
| Mar 31, 2020 | 74,000.00 |
| Mar 31, 2020 | 74,000.00 |
| Dec 31, 2019 | -39,676.00 |
| Dec 31, 2019 | -39,676.00 |
| Sep 30, 2019 | -2,330.00 |
| Sep 30, 2019 | -2,330.00 |
| Jun 30, 2019 | 28,446.00 |
| Jun 30, 2019 | 28,446.00 |
| Mar 31, 2019 | 13,560.00 |
| Mar 31, 2019 | 13,560.00 |
| Dec 31, 2018 | 25,700.00 |
| Dec 31, 2018 | 25,700.00 |
| Sep 30, 2018 | 8.06 Mn |
| Sep 30, 2018 | 8.06 Mn |
| Jun 30, 2018 | 7.72 Mn |
| Jun 30, 2018 | 7.72 Mn |
| Mar 31, 2018 | -21,826.00 |
| Mar 31, 2018 | -21,826.00 |
| Mar 31, 2017 | 397,235.00 |
| Mar 31, 2017 | 397,235.00 |
| Dec 31, 2016 | -106,946.00 |
| Dec 31, 2016 | -106,946.00 |
| Jun 30, 2016 | 1.09 Mn |
| Jun 30, 2016 | 1.09 Mn |
| Mar 31, 2016 | -733,356.00 |
| Mar 31, 2016 | -733,356.00 |
| Dec 31, 2015 | -389,596.00 |
| Dec 31, 2015 | -389,596.00 |
| Dec 31, 2014 | -472,026.00 |
| Dec 31, 2014 | -472,026.00 |
| Sep 30, 2014 | 1.26 Mn |
| Sep 30, 2014 | 1.26 Mn |
| Mar 31, 2014 | 25,000.00 |
| Mar 31, 2014 | 25,000.00 |
| Dec 31, 2013 | 1.33 Mn |
| Dec 31, 2013 | 1.33 Mn |
| Sep 30, 2013 | -2.68 Mn |
| Sep 30, 2013 | -2.68 Mn |
| Jun 30, 2013 | -498,587.00 |
| Jun 30, 2013 | -498,587.00 |
| Mar 31, 2013 | -45,326.00 |
| Mar 31, 2013 | -45,326.00 |
| Dec 31, 2012 | 1.42 Mn |
| Dec 31, 2012 | 1.42 Mn |
| Jun 30, 2012 | 776,919.00 |
| Jun 30, 2012 | 776,919.00 |
| Mar 31, 2012 | 274,207.00 |
| Mar 31, 2012 | 274,207.00 |
| Dec 31, 2011 | -1.68 Mn |
| Dec 31, 2011 | -1.68 Mn |
| Sep 30, 2011 | 2,019.00 |
| Sep 30, 2011 | 2,019.00 |